The funding comes from a Massachusetts-Israel Innovation Partnership grant. MIIP is a collaboration between Israel and Massachusetts focused on encouraging and supporting innovation and entrepreneurship between Massachusetts’ and Israel’s life sciences, clean energy and technology sectors.
Lantheus, a Massachusetts-based developer, manufacturer and distributor of diagnostic imaging agents, will receive the grant upon signing a collaboration agreement with Israel-based Check-Cap to develop the capsule. Check-Cap is receiving a grant from the office of the chief scientist in Israel.
“We are pleased to have been selected to receive this important new grant that enables us to collaborate with Check-Cap on an innovative imaging product that can potentially change the way colon cancer is detected,” said Don Kiepert, president and CEO of Lantheus Medical Imaging, in the release. “As a global leader in diagnostic imaging, Lantheus is dedicated to providing physicians with breakthrough tools to enhance patient care. Teaming up with Check-Cap to develop and manufacture a cutting-edge imaging capsule further advances this ongoing commitment.”
Lantheus is headquartered in North Billerica, Mass.
Related Articles on Colorectal Cancer:
Study: Long-Term Use of Bisphosphonates Not Associated With Colorectal Cancer Risk
NB’s Good Samaritan Hospital Wins Colorectal Cancer Screening and Awareness Challenge
Study: Sigmoidoscopy Reduces Colorectal Cancer Rate
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
